Filing Details
- Accession Number:
- 0001415889-23-011778
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-02 18:29:59
- Reporting Period:
- 2023-07-31
- Accepted Time:
- 2023-08-02 18:29:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235912 | Cvrx Inc. | CVRX | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1869761 | Paul Verrastro | 9201 W Broadway Ave #650 Minneapolis MN 55445 | Chief Mktg & Strat Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-31 | 3,750 | $5.14 | 3,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-07-31 | 1,122 | $17.49 | 2,628 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-02 | 2,000 | $0.00 | 628 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-07-31 | 3,750 | $5.14 | 3,750 | $5.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,806 | 2031-01-04 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of 3,750 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on July 31, 2023 with sale prices ranging from $17.47 to $17.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Vests as to 25% of the shares on January 4, 2022 and vests as to 1/48th of the shares each month thereafter.
Billionaire Hedge Funds
